HOME >> MEDICINE >> NEWS
Cervical cancer vaccine may lose effectiveness during ovulation

A new study has found that a vaccine against human papillomavirus 16 (HPV16), the virus that causes cervical cancer, produces antibodies against HPV16 at the site where cervical cancer develops--a promising indication of the vaccine's effectiveness. However, antibody levels appear to decrease around ovulation, raising the possibility that the vaccine may be less effective during that time. The findings appear in the August 6 issue of the Journal of the National Cancer Institute.

A vaccine is considered promising if it can produce an immune response (determined by levels of antibodies) at disease-specific sites such as the cervix. Past studies have shown that an HPV16 vaccine can trigger an immune response and protect against HPV16 infection. However, most of these studies involved women who were taking oral contraceptives (which regulate menstruation), and it is unclear what effect changes in hormone levels during the natural menstrual cycle would have on the vaccine's effectiveness.

To examine the influence of menstrual cycle stage and oral contraceptive use on antibody levels, Denise Nardelli-Haefliger, Ph.D., of the Centre Hospitalier Universitaire Vaudois in Lausanne, Switzerland, and Douglas R. Lowy, M.D., of the National Cancer Institute, and their colleagues administered the HPV 16 vaccine to seven women who were taking oral contraceptives and 11 women who were ovulating. The researchers collected blood and cervical secretions twice a week for 5 weeks and determined concentrations of anti-HPV16 antibodies during different phases of the menstrual cycle.

All of the women had relatively high levels of antibodies in their cervical secretions after immunization. Among women taking oral contraceptives, antibody levels remained relatively constant throughout the menstrual cycle. In contrast, levels of vaccine-specific and total antibodies in ovulating women were highest during the proliferative phase of the menstrual cycle and lowes
'"/>

Contact: Linda Wang
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
5-Aug-2003


Page: 1 2

Related medicine news :

1. Cervical cancer treatment depends on patient age
2. Cervical cancer A single vaccine could benefit most women
3. Cervical tissue changes may explain false negative pap smears
4. Further Evidence On The Effect Of The UK Cervical Screening Programme
5. Cervical Screening Has Reduced Incidence And Mortality From Cervical Cancer
6. Vinegar Offers Dependable Test For Cervical Cancer
7. Women Who Have Invasive Cervical Cancer Benefit From Addition Of Chemotherapy To Radiation Treatment
8. Hormonal treatment improves survival in high-risk prostate cancer patients
9. International breast cancer prevention study launches in the United States and Canada
10. Unexpected benefit seen in treating HER-2 breast cancer with new preoperative drug combo
11. Cultural and social factors influence prostate cancer treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... ... meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s to ... and tested to meet the highest standard. , These products are also: ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... leader in post-acute health care, have expanded their existing home health joint venture ... , AccentCare has been operating a joint venture home health company with Asante, ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards ... recognizes editorial and design excellence across a range of sectors. This year’s program included ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand ... Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness will be ... Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... in wound care advancements to physician colleagues, skilled nursing facility medical directors and ... the Treacherous Waters of Wound Care." , "At many of these conferences we ...
Breaking Medicine News(10 mins):
(Date:9/19/2017)... Ky. , Sept. 19, 2017   ZirMed Inc ... predictive analytics, today announced that it has been ranked #1 ... Black Book™ Rankings 2017 User Survey. ZirMed was ... solution for large hospitals and medical centers over 200 beds ... Black Book,s healthcare technology user survey history. ...
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
(Date:9/12/2017)... YORK , Sept. 12, 2017   EcoVadis , the leading ... has published the first annual edition of its Global CSR Risk and ... companies evaluated by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 ... ... Index ...
Breaking Medicine Technology:
Cached News: